CD8A and cancer: In preclinical models, implantation of cancer cells can induce CD8+ T cell priming sufficient to establish T cell memory and can cause spontaneous rejection of immunogenic tumors1,48–51; in models where pre-existing anti-tumor immunity is not present, additional vaccination is necessary to permit tumor control by radiation and checkpoint inhibition52.